Guidance Before Reading
Critical Axes and Publication Limitations
- Article Type: Intervention. The topic is organized across five clinical decision axes, not through a global judgment.
- Evidence Basis: moderately / moderately / fully evaluated. This summary is written in clear clinical language.
- Bias Risk: low to moderate. Source integrity: sound. 5 evaluated sources, of which 1 is supporting (green), and 4 are with reservations (yellow).
- The core uncertainty does not concern *if*, but *how* the periimplant aftercare should be managed.
Clinical Question
What contribution does structured supportive periimplant therapy (SPT) make to the prevention of peri-implantitis and implant loss—and where does the reliable evidence end regarding interval, instrument choice, and adjunctive procedures?
Executive Summary
The local body of literature shows a consistent direction for supportive periimplant therapy: Regular, structured aftercare is associated with fewer signs of peri-implantitis and less implant loss. The strength of conclusion is moderate, based on a systematic review, a comprehensive review from a recent date, and three supplementary overview articles. [1-5]
The overall direction leans toward a supporting clinical benefit of aftercare. For this article, five axes are crucial: SPT adherence and implant prognosis, mucositis as an early reversible stage, instrument choice, adjunctive procedures, and risk-based recall interval.
The core uncertainty does not concern *if*, but *how*: The optimal interval, the ideal combination of instruments, and the role of adjunctive procedures like aPDT are not proven by controlled long-term comparisons. The bias risk is aggregated as low to moderate.
How DDJ Reads This Topic
The core conflict in periimplant aftercare is not the question of whether it is beneficial—that direction is consistent—but rather how optimally it should be designed. The available evidence supports aftercare as a principle, but not every detail of its execution.
DDJ treats this topic as an intervention article. This means: Five clinical sub-axes are evaluated separately, instead of giving a global judgment on SPT. Where an axis is supported by the body of literature, the article states that. Where the evidence is thin, that is also visible.
Internal scores guide the basis. Clinical questions, conflict zones, and consequences are made visible.
Claim Clusters and Decision Axes
Claim Cluster 1 — ddj_0015_c01
Regular Supportive Periodontal Therapy (SPT) and Implant Prognosis
Clinical Question: Does regular SPT affect the rates of peri-implantitis and implant loss?
Why this question matters: The fundamental question of whether structured follow-up ensures implant success is clinically central and determines the long-term management for every implant patient.
Evidence Status: Regular, structured supportive periimplant therapy is consistently associated with fewer signs of peri-implantitis and less implant loss than the absence or irregularity of follow-up care. A systematic review (Ramanauskaite & Tervonen, 2016) summarized 7 studies—in all of which poor SPT was associated with significantly higher rates of mucosal bleeding, deeper pockets, bone loss, and implant loss. [1] A comprehensive review from 2025 confirms that regular maintenance and optimal oral hygiene are critical for the prevention and management of periimplant diseases. [5]
Claim Strength: strong | Evidence Weight: high | Direction: Benefit
Where the signal is stable: The association between SPT adherence and lower risk of peri-implantitis/loss is consistent across multiple study designs.
Where the uncertainty begins: The optimal SPT interval is not proven by RCT comparisons of different recall frequencies. The general direction is consistent, but the parameterization is not.
Clinical Implication: SPT adherence should be considered a standard recommendation. The specific interval remains an individual clinical decision.
Claim Cluster 2 — ddj_0015_c02
Mucositis as a Reversible Early Stage
Clinical Question: Is periimplant mucositis reversible, and does treating it prevent progression to peri-implantitis?
Why this question matters: Early intervention for mucositis determines the clinical long-term course. If mucositis is overlooked or untreated, progression to irreversible peri-implantitis with bone loss is threatened.
Evidence Status: Periimplant mucositis—detectable by probing bleeding without radiographic bone loss—is reversible and must be treated early to prevent progression to peri-implantitis. A comprehensive review from 2025 shows that early diagnosis and effective management of mucositis are crucial for long-term success; mechanical debridement is first-line, and reversibility through biofilm control is proven. [5] A clinical review on decision-making for periimplant mucositis confirms: Early detection and prompt intervention are key to preventing peri-implantitis progression. [4]